期刊文献+

乙二醇壳聚糖接枝羧甲基β-环糊精用于运载疏水性抗癌药物甲氨蝶呤 被引量:1

Glycol chitosan-graft-carboxymethyl β-cyclodextrin as carrier of hydrophobic anticancer drug methotrexate
下载PDF
导出
摘要 利用简单的交联反应合成乙二醇壳聚糖接枝羧甲基β-环糊精(GCH-g-CMβ-CD),通过红外光谱、核磁共振谱和浓硫酸-苯酚降解法对其进行表征.将GCH-g-CMβ-CD用于运载疏水性抗癌药物甲氨蝶呤(MTX),应用表面等离子体激元共振仪在线原位监测其与MTX的结合,紫外吸收分光光度法测定主客体分子的结合比为1∶1.证明GCH-g-CMβ-CD通过CMβ-CD的疏水空腔与MTX结合,形成稳定的水溶性复合物.因此,GCH-g-CMβ-CD有望用于疏水性抗肿瘤药物的运载. Glycol chitosan-graft-carboxymethylfl-cyclodextrin (GCH-g-CM fl-CD) was synthesized by a simple cross-linking reaction, and the products were characterized by FT-IR,13 C-NMR, and HESO4-phenol degradation method. Interaction between GCH-g-CM β-CD and hydrophobic anticancer drug methotrexate (MTX) was studied by surface plasmon resonance (SPR) in real time and in situ. UV-vis spectroscopy analysis indicated that each CM β-CD unit binds one MTX molecule, which showed that MTX can be successfully loaded into the hydrophobic cavities of grafted CM β-CDs. The results indicated that the newly synthesized GCH-g-CM fl-CD can be used as hydrophobic anticancer drug carrier.
作者 谭海娜 姚鑫
出处 《中国科学院研究生院学报》 CAS CSCD 北大核心 2013年第2期200-205,共6页 Journal of the Graduate School of the Chinese Academy of Sciences
基金 国家自然科学基金(20877097) 中国科学院研究生院院长基金(Y15102CN00) 天然药物及仿生药物国家重点实验室开放基金(K20120207)资助
关键词 乙二醇壳聚糖接枝羧甲基β-环糊精 药物载体 抗癌药物 甲氨蝶呤 表面等离子体 激元共振仪 glycol chitosan-grafi-carboxymethyl β-cyclodextrin drug carrier anticancer drug methotrexate surface plasmon resonance
  • 相关文献

参考文献1

二级参考文献5

共引文献6

同被引文献23

  • 1曹劝省,张凯伦,付平,孙宗全,董念国.可降解生物材料聚已丙交酯的生物相容性研究[J].陕西医学杂志,2008,37(2):153-155. 被引量:2
  • 2莫丽都尔,陈汉,李学敏,陈红丽,史艳萍,张其清.关节腔注射用甲氨蝶呤缓释微球的制备及体内外释药研究[J].中国新药杂志,2007,16(15):1187-1191. 被引量:6
  • 3Song X, Liang F, Liu N, et al. Construction and character- ization of a novel DNA vaccine that is potent antigen-spe- cific tolerizing therapy for experimental arthritis by in- creasing CD4+, CD25 Treg cells and inducing Thl to Th2 shift in both cells and cytokines[J]. Vaccine, 2009,27 (5) : 690.
  • 4Liang LS, Jackson J, Min W, et al. Methotrexate loaded poly (L-lactic acid) microspheres for intra-articular deliv- ery of methotrexate to the joint[J]. J Pharm Sci, 2004, 93 (4):943.
  • 5Bakker MF, Jacobs JW, Welsing PM, et al. Are switches from oral to subcutaneous methotrexate or addition of ci- closporin to methotrexate useful steps in a tight control treatment strategy for rheumatoid arthritis? A post hoc analysis of the CAMERA study[J]. Ann Rheum Dis, 2010, 69(10):1 849.
  • 6Wang X, Liu P, Yang W, et al. Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood-brain barrier[J]. lnt J Nanomedicine , 2014, doi: 10.2147/IJN.$69845.
  • 7Chen AZ, Wang GY, Wang SB, et al. Formation of me- thotrexate-PLLA-PEG-PLLA composite microspheres by microencapsulation through a process of suspension-en- hanced dispersion by supercritical CO2[J]. Int J Nanomedi- cine,2012,7(14):3 013.
  • 8高科攀,蒋新国.聚山梨酯80修饰的聚氰基丙烯酸正丁酯纳米粒提高甲氨蝶呤大鼠脑内浓度[C]//2004年中国药学会学术年会论文集.昆明:中国药学会,2004.
  • 9Trapani A, Denora N, IacobeUis G, et al. Methotrexate- loaded chitosan and glycolchitosan-based nanoparticles: a promising strategy for the administration of the anticancer drug to brain tumors[J]. AAPS Pharm Sci Tech, 2011, 12 (4) : 1 302.
  • 10Corem-Salkmon E, Ram Z, Daniels D, et al. Convection- enhanced delivery of methotrexate-loaded maghemite nanoparticles[J]. Int Y Nanomedicine, 2011, doi: 10.2147/ IJN.S23025.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部